The economics and uncertainties of drug development require successful companies to demonstrate early evidence of their compounds’ clinical efficacy and tolerance in humans. But what is the most efficient and cost-effective way to reach this milestone? MDS Pharma Services’ Drug Development Programs provide the solution. The knowledge and leadership of highly experienced scientists are leveraged to help clients design and execute comprehensive development strategies. This integrated service spans the research process for small and large molecule drugs from Lead Identification through Clinical Proof-of-Concept—and all the way into full clinical development.

Our team combines expertise in pharmacology, chemogenomics, drug metabolism, pharmacokinetics, analytical chemistry, toxicology and safety pharmacology, pharmaceutical formulation, biopharmaceutics, bioanalysis, clinical pharmacology, all phases of clinical research, regulatory strategy and submissions support.

Development & Regulatory Services

Drug Development

Biopharmaceutical Development

Regulatory Affairs

Program Management